Probiotic-guided CAR-T cells for solid tumor targeting
Engineered probiotics produce synthetic targets to facilitate immunotherapy of solid tumors by CAR T cells.
Related Articles
Extreme solar storm generated aurorae—and ‘surprise’
The biggest disturbance of Earth’s magnetic field in more than 20 years dazzled onlookers the world over
DNA damage induces p53-independent apoptosis through ribosome stalling
In response to excessive DNA damage, human cells can activate p53 to induce apoptosis. Cells lacking p53 can still undergo apoptosis upon DNA damage, yet…
News at a glance: Solar storm stuns, COVID-19 vaccine withdrawn, and fossils return to Brazil
The latest in science and policy
Taking climate-smart governance to the high seas
Comprehensive spatial planning in international waters is key to achieving ocean sustainability
An AAV capsid reprogrammed to bind human transferrin receptor mediates brain-wide gene delivery
Developing vehicles that efficiently deliver genes throughout the human central nervous system (CNS) will broaden the range of treatable genetic diseases. We engineered an adeno-associated…
How power shapes behavior: Evidence from physicians
Power—the asymmetric control of valued resources—affects most human interactions. Although power is challenging to study with real-world data, a distinctive dataset allowed us to do…
No humans needed: AI robots discover new laser materials on their own
Automated labs across the globe create, test, and assemble light-emitting compounds that could be used in advanced displays and telecom devices
Stereoscopic artificial compound eyes for spatiotemporal perception in three-dimensional space
An artificial stereoscopic compound eye uses in- and near-sensor computing for precise object tracking.
An inflamed brain can trigger psychosis. The search is on for patients who might be cured
The discovery of rogue antibodies behind paranoia, hallucinations, and other symptoms could bring a “paradigm shift” to psychiatry
An inflamed brain can trigger psychosis. The search is on for patients who might be cured
The discovery of rogue antibodies behind paranoia, hallucinations, and other symptoms could bring a “paradigm shift” to psychiatry